These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3044339)

  • 21. Monoclonal antibodies and immunoconjugates for cancer treatment.
    Baldwin RW; Byers VS; Pimm MV
    Cancer Chemother Biol Response Modif; 1988; 10():397-415. PubMed ID: 3079393
    [No Abstract]   [Full Text] [Related]  

  • 22. [Application of monoclonal antibody for cancer therapy].
    Yamaguchi T; Takahashi T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):157-62. PubMed ID: 8311485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody conjugates and therapeutic strategies.
    McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ
    Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthracycline derivatives in new drug development programs.
    Rozencweig M; De Sloover C; Von Hoff DD; Tagnon HJ; Muggia FM
    Cancer Treat Rep; 1979 May; 63(5):807-8. PubMed ID: 455322
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody-cytotoxic agent conjugates for cancer therapy.
    Chen J; Jaracz S; Zhao X; Chen S; Ojima I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):873-90. PubMed ID: 16296784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates.
    Takahashi H; Adachi K; Yamaguchi F; Teramoto A
    Anticancer Res; 1999; 19(5B):4151-5. PubMed ID: 10628367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugates.
    Gesson JP; Jacquesy JC; Mondon M; Petit P; Renoux B; Andrianomenjanahary S; Dufat-Trinh Van H; Koch M; Michel S; Tillequin F
    Anticancer Drug Des; 1994 Oct; 9(5):409-23. PubMed ID: 7945725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental study on targeting therapy of human hepatocellular carcinoma in nude mice using adriamycin-anti-transferrin receptor conjugate].
    Wang F; Li S; Lin J
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):354-7. PubMed ID: 8697974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice.
    Morelli D; Ménard S; Colnaghi MI; Balsari A
    Cancer Res; 1996 May; 56(9):2082-5. PubMed ID: 8616854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward an effective targeted chemotherapy for multiple myeloma.
    Polson AG; Sliwkowski MX
    Clin Cancer Res; 2009 Jun; 15(12):3906-7. PubMed ID: 19509145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody 791T/36 immunoconjugates for cancer treatment.
    Baldwin RW; Byers VS
    Targeted Diagn Ther; 1989; 2():53-72. PubMed ID: 2519550
    [No Abstract]   [Full Text] [Related]  

  • 32. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposome and adriamycin].
    Li WJ; Qian HN; Lu WY
    Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):296-8, 319. PubMed ID: 7956556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer].
    Wang WG; Wang SH; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1995; 30(8):583-7. PubMed ID: 8571778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anthracycline analogs: re-assessments and prospects.
    Carter SK
    Cancer Treat Rep; 1979 May; 63(5):935-6. PubMed ID: 455336
    [No Abstract]   [Full Text] [Related]  

  • 35. Monoclonal antibodies and immunoconjugates for cancer treatment.
    Baldwin RW; Byers VS
    Cancer Chemother Biol Response Modif; 1987; 9():409-31. PubMed ID: 3079412
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoclonal antibody therapy of cancer.
    Weiner LM
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):43-51. PubMed ID: 10561017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting.
    Petit T; Borel C; Ghnassia JP; Rodier JF; Escande A; Mors R; Haegelé P
    Clin Cancer Res; 2001 Jun; 7(6):1577-81. PubMed ID: 11410493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
    Wang WG; Xu LN; Zhang SH; Xue YC; Zhen YS
    Yao Xue Xue Bao; 1997 Sep; 32(9):669-74. PubMed ID: 11596291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target therapy of ovarian carcinoma by monoclonal antibodies bearing chemical drugs entrapped in liposomes.
    Qian HN; Li WJ
    Chin Med J (Engl); 1993 May; 106(5):343-7. PubMed ID: 8404276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody therapy for solid tumors.
    Green MC; Murray JL; Hortobagyi GN
    Cancer Treat Rev; 2000 Aug; 26(4):269-86. PubMed ID: 10913382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.